The board of Dingdang Health Technology Group Ltd. will convene on 21 August 2026 to review and approve the Group’s unaudited interim results for the six months ended 30 June 2026. The agenda also includes deliberation on the payment of an interim dividend, if any. Chairman Yang Wenlong will preside over the meeting, which will take place in Hong Kong. The current board comprises six executive directors and three independent non-executive directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments